1. “Corporate Governance Gap” InVivo (NVIV) Delays Listing to National Securities

    “Corporate Governance Gap” InVivo (NVIV) Delays Listing to National Securities

    Recent challenges to biotechnology companies have been in the form of corporate governance issues, especially those undergoing rapid growth. Two companies in particular, InVivo (NVIV) and Amarantus Bioscience (AMBS) both stand out for their recent, ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned